VIBOSTOLIMAB
UNII 5XO3JF0FEK

Substance Identification & Data

This profile provides standardized clinical and technical data for Vibostolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5XO3JF0FEK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2231305-30-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5XO3JF0FEK

CAS Registry Number

2231305-30-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VIBOSTOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C140041

National Cancer Institute reference terminology for clinical and research data.

INN ID

11178

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-215

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vibostolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VIBOSTOLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT (T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS)) (HUMAN-MUS MUSCULUS MONOCLONAL C011 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C011 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS, V-SET AND IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN 9, V-SET AND TRANSMEMBRANE DOMAIN-CONTAINING PROTEIN 3)HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN HUMANIZED (1-449) (VH (HOMO SAPIENS IGHV1-69*08 (85%) (IGHD)-IGHJ3*01 (93%)) (8.8.12) (1-119)-HOMO SAPIENS IGHG1*01 (100%) (120-449)) (222-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-27*01 (85%) IGKJ5*01 (92%))(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%) (108'-214')), DIMER (228-228'':231-231'')-BISDISULFIDE

MK-7684A COMPONENT VIBOSTOLIMAB

T-CELL IMMUNOGLOBULIN AND IMMUNORECEPTOR TYROSINE-BASED INHIBITORY MOTIF INHIBITOR MK-7684

VIBOSTOLIMAB [INN]

VIBOSTOLIMAB [USAN]

VIBOSTOLIMAB [WHO-DD]